Tag: VTE
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Prolonged TV watching may increase risk of venous thromboembolism
A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...
New study addresses thromboembolic complications in COVID-19 patients
There is an “urgent need” to improve specific venous thromboembolism (VTE) diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19...
FDA approval granted to Thrombolex for Bashir Endovascular Catheter-Short Basket
Thrombolex has announced that the company has received US Food and Drug Administration (FDA) clearance for the Bashir Endovascular Catheter - Short Basket (BEC...
FDA approves new 10mg dosing for rivaroxaban to reduce continued risk...
Janssen Pharmaceuticals has announced that the FDA has approved the 10mg once-daily dose of rivaroxaban (Xarelto) for reducing the continued risk for recurrent venous...
